NCT05603182View on ClinicalTrials.gov

A Study of PRA052 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

96

Participants

Timeline

Start Date

November 7, 2022

Primary Completion Date

February 21, 2024

Study Completion Date

February 21, 2024

Conditions

Healthy

Interventions

DRUG

PRA052

PRA052

OTHER

Placebo

Placebo

Trial Locations (1)

68502

Prometheus Clinical Site, Lincoln

All Listed Sponsors

lead

Prometheus Biosciences, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

INDUSTRY